Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma
Open Access
- 19 October 2006
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 21 (1) , 169-174
- https://doi.org/10.1038/sj.leu.2404445
Abstract
CD307 is a differentiation antigen expressed in B-lineage cells. One soluble and two membrane-bound forms have been predicted and an enzyme-linked immunosorbent assay (ELISA) for soluble CD307 established. Our goal was to determine if CD307 is expressed on the surface of cells from patients with multiple myeloma (MM), chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL) and other B-cell malignancies and if soluble CD307 levels are elevated in the blood of patients with these B-cell malignancies. Cells and blood were collected from patients. Expression of CD307 was measured by flow cytometry and blood levels of soluble CD307 by ELISA. High soluble CD307 levels were detected in 21/43 (49%) of patients with MM, 36/46 (78%) with CLL and 9/24 (38%) with MCL. Soluble CD307 levels correlated with plasma cell percentages in bone marrow aspirates in MM and total white blood cells in CLL. CD307 on the cell membrane was detected by flow cytometry in 8/8 MM, 23/29 CLL and 4/5 MCL samples. Because CD307 is present on malignant cells from patients with MM, CLL and MCL, CD307 may be a useful therapeutic target for the treatment of these diseases.Keywords
This publication has 20 references indexed in Scilit:
- Novel Immune-Based Treatment Strategies for Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2005
- Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistryCellular Immunology, 2005
- Staging and Classification of LymphomaSeminars in Nuclear Medicine, 2005
- Flow cytometric immunophenotypic profiles of mature gamma delta T‐cell malignancies involving peripheral blood and bone marrowCytometry Part B: Clinical Cytometry, 2005
- An extended family of Fc receptor relativesEuropean Journal of Immunology, 2005
- Effect of Single-Agent Rituximab Given at the Standard Schedule or As Prolonged Treatment in Patients With Mantle Cell Lymphoma: A Study of the Swiss Group for Clinical Cancer Research (SAKK)Journal of Clinical Oncology, 2005
- Differential B cell expression of mouse Fc receptor homologsInternational Immunology, 2004
- Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene familyImmunological Reviews, 2002
- BXMAS1 Identifies a Cluster of Homologous Genes Differentially Expressed in B CellsBiochemical and Biophysical Research Communications, 2001
- The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997Laboratory Investigation, 2000